Indian Healthcare industry is evolving and growing at a steady rate. Healthcare is currently one of the largest sectors whether we talk in terms of revenue or employment.

Today, Indian pharma and biotech market focuses on following three areas. (1) Generic and bio-similar market (2) Contract research, manufacturing and clinical services and (3) Innovative NCE R&D based pharmaceutical sector.

The Indian pharmaceutical industry is one of the most significantly emerging markets and has been witnessing phenomenal growth in recent years and is likely to be in the top 10 global markets by value by 2020.

Indian Pharmaceuticals industry has been proud if its ability to develop innovative Fixed Dose Combinations (FDCs) and has used that effectively as a differentiation strategy.

In light of these market forces, pharmaceutical companies need to look outside of their organization for opportunities and the consulting community could prove to be a strong helping hand in this endeavour.

Biopharmaceuticals is arguably amongst the most sophisticated achievements of modern science. The paradigm change in cancer treatment is perhaps the best example of this sophistication and its potential to change people’s lives....

The Pharma is one of the world’s most profitable industries. The Indian pharmaceuticals market is the third largest in terms of volume and thirteenth largest in terms of value, as per a report by Equity Master.

Over a significant span of time the industry has witnessed tremendous growth in biologics, over-the-counter (OTC) medicines and generic drugs.

There are many leading companies which are becoming more and more unconventional in their approach. Google is one of those companies which have a series of schemes to enrich the life at work.

The global market is swelling, and it is bringing a bounty of business and opportunities to the Indian shores. Currently, India is vying for the limelight with China, but greater global appeal, flexible political scenario and a better socio-economi